Biren Amin of Piper Sandler, Initiated "Apellis Pharmaceuticals, Inc." (APLS) at Hold and Held Target at $46 on, May 31st, 2024.
Biren has made no other calls on APLS in the last 4 months.
There are 10 other peers that have a rating on APLS. Out of the 10 peers that are also analyzing APLS, 3 agree with Biren's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Derek Archila of "Wells Fargo" Maintained at Hold with Decreased Target to $48 on, Thursday, May 23rd, 2024
- Graig Suvannavejh of "Mizuho" Maintained at Hold with Decreased Target to $52 on, Monday, April 29th, 2024
- Laura Chico of "Wedbush" Maintained at Hold with Decreased Target to $57 on, Wednesday, April 17th, 2024
These are the ratings of the 7 analyists that currently disagree with Biren
- Douglas Tsao of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $92 on, Tuesday, May 28th, 2024
- Eliana Merle of "UBS" Maintained at Strong Buy with Decreased Target to $85 on, Wednesday, May 8th, 2024
- Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $85 on, Wednesday, May 8th, 2024
- Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $60 on, Wednesday, May 8th, 2024
- Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $79 on, Wednesday, March 6th, 2024
- Colleen Kusy of "Baird" Reiterated at Buy and Held Target at $81 on, Tuesday, February 6th, 2024
- Akash Tewari of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $80 on, Monday, February 5th, 2024
